Evaluating Investigational Medical Device for Breast Tumor Diagnosis Using Diffusion Optical Spectroscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

November 29, 2024

Study Completion Date

December 16, 2024

Conditions
Breast CancerBreast TumorMammary Carcinoma, Human
Interventions
DEVICE

ORIGO

The device measurement is first performed on the breast area with the lesion, followed by the measurement of the corresponding area in the contralateral breast for comparison.

Trial Locations (5)

Unknown

Seoul National University Bundang Hospital, Seongnam-si

Kangbuk Samsung Hospital, Seoul

Korea University Anam Hospital, Seoul

Severance Hospital, Seoul

Yongin Severance Hospital, Yongin-si

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Olive Healthcare

INDUSTRY

NCT06597175 - Evaluating Investigational Medical Device for Breast Tumor Diagnosis Using Diffusion Optical Spectroscopy | Biotech Hunter | Biotech Hunter